Catalyst Wire Dossier Catalyst Wire Dossier

Placentex Mastelli (Pdrn)

polydeoxyribonucleotide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Placentex Mastelli (Pdrn), covering 2012-09-11 to 2012-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers [Phase 4]

See pricing